Edgewise Therapeutics reported cash from operations of -$42.47M and free cash flow of -$42.50M for the quarter ended Jun 2026, down 30.3% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||
| Net Income | -12.95M | -12.70M | -14.66M | -16.07M | -17.50M | -19.41M | -22.84M | -21.47M | -25.71M | -30.14M | -28.52M | -31.50M | -34.13M | -39.66M | -40.80M | -36.12M | -40.67M | -50.22M | -49.01M | -57.33M | ||||||
| Depreciation and Depletion | 0.47M | 0.48M | 0.54M | 0.58M | 0.51M | 0.52M | 0.52M | 0.53M | 0.54M | 0.54M | ||||||||||||||||
| Share-based Compensation | 5.68M | 1.87M | 5.49M | 5.06M | 5.04M | 3.74M | 5.04M | 5.04M | 5.04M | 5.15M | 5.04M | 5.22M | 6.88M | 7.74M | 9.06M | 7.73M | 8.09M | 9.88M | 8.71M | 9.36M | ||||||
| Cash from Operations | -8.26M | -9.42M | -12.57M | -16.25M | -11.96M | -11.86M | -22.83M | -20.23M | -22.06M | -26.83M | -28.60M | -26.10M | -27.37M | -26.96M | -37.87M | -32.58M | -34.78M | -38.59M | -42.54M | -42.47M | ||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||
| Amortizatization of Intangibles | -0.67M | -0.41M | -0.13M | 1.75M | 2.08M | 2.90M | 2.38M | 2.17M | 3.15M | 3.55M | 3.24M | 2.60M | 1.92M | 2.20M | 2.06M | 1.48M | 1.01M | 0.81M | ||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.47M | 0.48M | 0.54M | 0.58M | 0.51M | 0.52M | 0.52M | 0.53M | 0.54M | 0.54M | ||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||
| Change in Account Payables | -0.52M | 1.55M | 1.19M | -2.65M | 0.94M | 0.58M | -0.16M | -0.31M | 1.76M | -1.38M | 0.78M | 1.89M | -1.03M | 0.09M | 2.86M | -0.15M | -2.13M | -0.30M | 1.45M | 0.78M | ||||||
| Change in Accured Expenses | 1.88M | -0.55M | -1.45M | 0.68M | 0.58M | 1.53M | -1.96M | 2.90M | -0.57M | 1.29M | -2.77M | 1.32M | 1.94M | 3.87M | -6.08M | 1.66M | 2.36M | 4.43M | -6.75M | 2.90M | ||||||
| Other Working Capital Changes | -1.06M | 0.44M | -0.40M | 1.94M | 0.19M | 1.19M | 0.36M | 1.66M | 1.16M | 0.38M | -0.16M | -0.75M | -0.79M | -1.59M | 1.48M | 2.47M | 1.30M | 2.71M | -3.04M | 0.58M | ||||||
| Investing Activities | ||||||||||||||||||||||||||
| Capital Expenditures | 0.45M | 0.08M | 0.37M | 0.55M | 1.66M | 2.97M | 4.37M | 0.76M | 0.46M | 0.16M | 0.30M | 0.22M | 0.52M | 0.27M | 0.04M | 0.05M | 0.09M | 0.07M | 0.26M | 0.03M | ||||||
| Change in Acquisitions & Divestments | 10.20M | 25.80M | 36.88M | 59.77M | 30.28M | 69.86M | 69.76M | 114.12M | 94.50M | 66.00M | 58.71M | 77.67M | 60.24M | 81.30M | 151.12M | 78.00M | 90.00M | 108.19M | 108.88M | 108.81M | ||||||
| Cash from Investing Activities | -31.61M | 14.12M | 31.39M | -0.05M | -26.32M | -75.60M | 49.04M | 3.44M | 23.42M | 26.98M | -268.31M | 37.37M | 25.36M | 20.92M | 43.90M | -162.17M | 35.72M | 49.76M | 2.43M | 78.49M | ||||||
| Financing Activities | ||||||||||||||||||||||||||
| Other financing activities | 0.07M | 0.26M | 0.05M | 0.03M | 0.02M | 0.32M | 0.26M | 1.93M | 1.58M | 3.55M | 2.43M | 2.26M | 0.23M | 1.66M | 3.65M | 12.17M | 2.29M | |||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 2.25M | 3.52M | 4.00M | 2.82M | 4.27M | |||||||||||||||||||||
| Net Equity Issued and Repurchased | -0.56M | 239.15M | 0.26M | |||||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||
| Cash from Financing Activities | 0.04M | 0.29M | 0.07M | 0.18M | 129.69M | -0.30M | 0.02M | 0.37M | -0.21M | 52.99M | 241.07M | 1.95M | 3.33M | 2.90M | 2.22M | 188.23M | 1.66M | 3.98M | 12.17M | 3.09M | ||||||
| Change in Cash | -39.83M | 5.00M | 18.89M | -16.11M | 91.41M | -87.75M | 26.24M | -16.42M | 1.15M | 53.14M | -55.83M | 13.22M | 1.32M | -3.14M | 8.26M | -6.52M | 2.60M | 15.14M | -27.94M | 39.11M | ||||||
| Free Cash Flow | -8.71M | -9.50M | -12.94M | -16.80M | -13.62M | -14.82M | -27.19M | -20.99M | -22.52M | -26.99M | -28.89M | -26.32M | -27.89M | -27.23M | -37.91M | -32.63M | -34.87M | -38.66M | -42.80M | -42.50M | ||||||
| Net Cash Flow | -39.83M | 5.00M | 18.89M | -16.11M | 91.41M | -87.75M | 26.24M | -16.42M | 1.15M | 53.14M | -55.83M | 13.22M | 1.32M | -3.14M | 8.26M | -6.52M | 2.60M | 15.14M | -27.94M | 39.11M |